Introduction
The process of programmed cell death, or apoptosis, is generally characterized by distinct morphological characteristics and energy-dependent biochemical mechanisms. 1 In the apoptotic cells, biochemical changes such as protein cleavage, protein cross-linking, DNA breakdown, and phagocytic recognition are some of the diagnostic presentations. 1 Among these parameters, Bcl-2, a gene located at chromosome 18q21, encodes a protein that blocks programmed cell death, while the bax protein is a member of the bcl-2 family that promotes apoptosis. 2, 3 Generally, one of the standard ways to determine the vulnerability of a cell to apoptosis is the estimating of bax to bcl-2 ratio. 4, 5 Hypoxia by inducing apoptosis as well as necrosis is a well-known cause of cell death. 6 In the cardiac myocytes, a possible role for Bcl-2 and Bax proteins has been proposed in hypoxia-induced apoptosis. 7, 8 Ghrelin, a 28 amino-acid peptide, has diverse physiological functions in the body. [9] [10] [11] One of its recently found actions is the anti apoptotic effects. [12] [13] [14] This effect of ghrelin, at least in the cortical nerons, to some extent has been attributed to regulating of Bcl-2 family. 15 In the case of cardiomyocytes, it has been shown that ghrelin can protect these cells from different types of injuries, including apoptosis. [16] [17] [18] [19] However, the effect of ghrelin on the apoptosis rate in the cardiac tissue of animals lived in chronic hypoxia has not been explored yet. Base on this background, the aim of the present study is evaluating the effect of ghrelin on the Bax/Bcl-2 ratio in the heart of chronic hypoxic rats. 
Materials and Methods

Animals and chronic hypoxia model design
Standard Curve
Efficiency of RT-PCR reaction was determined by standard curve, which was derived from the 10-fold serial dilution of a positive PCR product by a customary RT-PCR. Logarithms of concentrations were plotted against target gene cycling threshold (Ct) of serial dilution. Bcl2, Bax, and ACTB efficiencies were 97%, 100 and 99% respectively. 
Statistical analysis
Normal distribution of data was evaluated using Stata software with qnorm program version 11. Data was analyzed by statistical SPSS software, version 16.
Variables that had normal distribution were reported as means and standard deviations. Medians were reported for the variables whose distribution deviated from the normal distribution. Differences between groups were evaluated using the Kruskal-Wallis test, and comparisons gene expression levels between hypoxia or hypoxia with ghrelin and the control group was performed with the Mann-Whitney test. All tests were two-tailed and a 5% significance level was applied.
Results
Comparison of Bcl2 and Bax gene expression between hypoxic, hypoxic with ghrelin and normal heart tissue
In spite of the wide range of individual values of Bcl2 or Bax, median expression of Bax mRNA in heart tissue of the examined groups were different (p=0.001) (Figure 1 ). However, there were no significant differences in Bcl2 mRNA expression between examing groups (p=0.617) (Figure 2 ). 
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Effect of chronic hypoxia on Bcl-2 and Bax expression in the heart
After 2-weeks of hypoxia, median expression of Bax mRNA in the heart tissue was increased compared to control animals (P = 0.008). However, there was no significant differences in Bcl2 mRNA expression between examine groups (p=0.674)
Effect of ghrelin on Bcl-2 and Bax gene expression during hypoxia
The median expression of Bax mRNA in the heart tissue of the hypoxic + ghrelin group was increased compared to hypoxia + saline group (p=0.093). However, this deference was not statistically significant. Furthermore, there were no significant differences in Bcl-2 mRNA expression between these groups (p=0.248).
Comparison of Bcl2 and Bax gene expression between hypoxia with ghrelin and normal heart tissue
The expression of Bax transcripts in the heart tissue of the hypoxic with ghrelin group were increased compared to normal group (p<0.001). However, there were no significant differences in Bcl-2 mRNA expression between these groups (p=0.645).
Comparison of the Bax/Bcl-2 ratio between hypoxic, hypoxic with ghrelin and normal heart tissue
The Bax/Bcl-2 expression ratio in the heart tissue of the examined groups was significantly different (p=0.001) (Figure 3 ).
Effect of chronic hypoxia on the Bax/Bcl-2 ratio in the heart
The Bax/Bcl-2 ratio increased due to living in hypoxia in comparison with normal animals (P=0.005). 
Effect of ghrelin on the Bax/Bcl-2 ratio in the chronic hypoxia heart
Treatment by ghrelin significantly increased the Bax/Bcl-2 ratio in the hypoxia + ghrelin group compared to the hypoxia+saline group and normal group (p=0.042 and P= 0.001, respectively).
Discussion
According to the results of this study, living in chronic hypoxic condition leads to increase of the Bax/Bcl-2 ratio in the heart of animals. This ratio, as a reliable index for apoptosis, 4, 5 can indicate the increase of cell death rate in cardiomyocytes, although it was not accompanied by histomorphological assessment. These findings are consistent with that found by Nishikawa and his coworkers. 21 A similar result has been presented by Yang and colleagues. 22 However, it is notable that the mentioned researches have been performed in an in-vitro model while our data validates the previous works through an in-vivo study. To date, many studies have demonstrated the antiapoptosis effect of ghrelin in different cell lines and by special mechanisms. For example, Yang et al. have shown that ghrelin diminishes apoptosis signal-regulating kinase 1 activity via upregulation of heat-shock protein 70. 12 Zhang and his colleagues have indicated that ghrelin reduces cell apoptosis in pancreatic beta cell line via interfering in mitogen-activated protein kinase/phosphoinositide 3-kinase pathways. 13 Granado and coworkers have mentioned that treatment by Ghrelin protect lactotrophs from apoptosis in a diabetic rat model. 14 Furthermore, the beneficiary effect of ghrelin treatment against cell apoptosis has been demonstrated in similar works about cardiac myocytes. [17] [18] [19] Conversely, ghrelin treatment in the present study enhanced the apoptosis index, the Bax/Bcl-2 ratio, in the heart of hypoxic animals. In contrast with our study, it would be better to emphasis that much of the pointed out investigations were in vitro and the cause of apoptosis was not chronic hypoxia. In response to hypoxia, cardiac myocytes switch from oxidative metabolism to anaerobic glycolysis. 23 In such condition, some research groups believe that glycolysis exaggerates the rate of cell death through acid production. 24, 25 Kubasiak, and his colleagues demonstrated that hypoxia in the presence of acidosiscould be due to glycolysis-activates cardiac myocyte apoptosis, which is mediated by BNIP3, a Bcl-2 family protein. 26 Furthermore, Luo and coworkers mentioned that hypoxia inducible factor-1alpha induces activity of the glycolysis pathway in A549 cells, carcinomic human alveolar basal epithelial cells, and decreases the pH of the culture medium, resulting in increased cellular apoptosis. 27 Previously, we have shown that ghrelin administration in chronic hypoxic rats increases the gene expression of aldolase, a key enzyme of glycolisys, in the heart of these animals. 28 Although this finding could describe a positive role for ghrelin about the heart metabolism in hypoxia, but it seems that it may deteriorate the cardiomyocytes survival in the chronic state. We are not sure that ghrelin usage amplifies glycolysis pathway entirely leading to acid production in the heart, but it would be a possible reason for anti cardioprotection action of ghrelin showed in the present observation. However, finding the main mediator of this effect of ghrelin should be under scrutiny.
Conclusion
Taken together, besides the result of the present study, the positive roles of ghrelin in cardioprotection could not be denied. Since the condition of this study is special, it would be better to examine different doses of ghrelin in distinct O2 pressures and also different durations of experience.
